Australia markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
65.99-0.52 (-0.78%)
As of 9:36AM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 583.09B
Enterprise value 3115.98B
Trailing P/E 274.96
Forward P/E 19.94
PEG ratio (5-yr expected) 13.13
Price/sales (ttm)3.25
Price/book (mrq)4.36
Enterprise value/revenue 34.54
Enterprise value/EBITDA 78.79

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-14.30%
S&P500 52-week change 344.65%
52-week high 380.92
52-week low 356.56
50-day moving average 365.30
200-day moving average 362.83

Share statistics

Avg vol (3-month) 37.75M
Avg vol (10-day) 38.82M
Shares outstanding 51.26B
Implied shares outstanding 6N/A
Float 1.25B
% held by insiders 10.09%
% held by institutions 179.65%
Shares short (14 Apr 2021) 426.01M
Short ratio (14 Apr 2021) 43.61
Short % of float (14 Apr 2021) 42.07%
Short % of shares outstanding (14 Apr 2021) 42.07%
Shares short (prior month 14 Mar 2021) 422.52M

Dividends & splits

Forward annual dividend rate 42.84
Forward annual dividend yield 44.27%
Trailing annual dividend rate 32.75
Trailing annual dividend yield 34.13%
5-year average dividend yield 43.23
Payout ratio 41,100.00%
Dividend date 328 Jun 2021
Ex-dividend date 413 Jun 2021
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 1.18%
Operating margin (ttm)45.76%

Management effectiveness

Return on assets (ttm)11.49%
Return on equity (ttm)1.33%

Income statement

Revenue (ttm)25.56B
Revenue per share (ttm)20.36
Quarterly revenue growth (yoy)15.80%
Gross profit (ttm)21B
EBITDA 13.2B
Net income avi to common (ttm)301M
Diluted EPS (ttm)0.24
Quarterly earnings growth (yoy)11.50%

Balance sheet

Total cash (mrq)6.25B
Total cash per share (mrq)4.98
Total debt (mrq)38.82B
Total debt/equity (mrq)204.72
Current ratio (mrq)1.36
Book value per share (mrq)15.12

Cash flow statement

Operating cash flow (ttm)9.34B
Levered free cash flow (ttm)10.43B